Rui L, Lindbaek M, Gjelstad S
Scand J Prim Health Care. 2022; 40(3):331-338.
PMID: 36369890
PMC: 9848284.
DOI: 10.1080/02813432.2022.2139363.
Locke J, Welk B, Macnab A, Rivers C, Kurban D, Nigro M
Spinal Cord. 2019; 57(12):1040-1047.
PMID: 31289367
DOI: 10.1038/s41393-019-0323-z.
Selin L, Harding G, Thomson M, Kennedy J, Urias B, Ronald A
Can J Infect Dis. 2012; 1(2):35-40.
PMID: 22553437
PMC: 3327960.
DOI: 10.1155/1990/482960.
Albert X, Huertas I, Pereiro I, Sanfelix J, Gosalbes V, Perrota C
Cochrane Database Syst Rev. 2004; (3):CD001209.
PMID: 15266443
PMC: 7032641.
DOI: 10.1002/14651858.CD001209.pub2.
Patel R, Welling P
Clin Pharmacokinet. 1980; 5(5):405-23.
PMID: 7408366
DOI: 10.2165/00003088-198005050-00001.
Effect of urinary acidifiers on formaldehyde concentration and efficacy with methenamine therapy.
Nahata M, Cummins B, McLeod D, Schondelmeyer S, Butler R
Eur J Clin Pharmacol. 1982; 22(3):281-4.
PMID: 7106162
DOI: 10.1007/BF00545228.
Role of cervicovaginal antibody in the pathogenesis of recurrent urinary tract infection in women.
Kurdydyk L, Kelly K, Harding G, Mirwaldt P, Thompson L, Buckwold F
Infect Immun. 1980; 29(1):76-82.
PMID: 6995343
PMC: 551077.
DOI: 10.1128/iai.29.1.76-82.1980.
Urinary tract infections in the elderly.
Kaye D
Bull N Y Acad Med. 1980; 56(2):209-20.
PMID: 6929194
PMC: 1805129.
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.
Wormser G, Keusch G, Heel R
Drugs. 1982; 24(6):459-518.
PMID: 6759092
DOI: 10.2165/00003495-198224060-00002.
[Immunologic aspects of 2 modes of prevention of urinary tract infection in children with trimethoprim-sulfamethoxazole].
Labbe J
Can Med Assoc J. 1984; 131(10):1229-33.
PMID: 6498674
PMC: 1483682.
Urinary tract infections: 1982--use of new concepts to guide therapy.
Neu H, Parry M
Bull N Y Acad Med. 1983; 59(3):288-300.
PMID: 6340781
PMC: 1911629.
Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
Haase D, Harding G, Thomson M, Kennedy J, Urias B, Ronald A
Antimicrob Agents Chemother. 1984; 26(4):481-4.
PMID: 6240223
PMC: 179948.
DOI: 10.1128/AAC.26.4.481.
Comparative in vitro activity of norfloxacin against urinary tract pathogens.
Haase D, Urias B, Harding G, Ronald A
Eur J Clin Microbiol. 1983; 2(3):235-41.
PMID: 6224679
DOI: 10.1007/BF02029524.
Co-trimoxazole from the therapeutic viewpoint.
Lode H
Infection. 1987; 15 Suppl 5:S222-6.
PMID: 3325432
DOI: 10.1007/BF01643192.
Prevention of recurrent acute cystitis by methenamine hippurate.
Brumfitt W, Hamilton-Miller J
Br Med J (Clin Res Ed). 1987; 295(6594):390-1.
PMID: 3115466
PMC: 1247239.
DOI: 10.1136/bmj.295.6594.390-b.
Prevention of recurrent acute cystitis by methenamine hippurate: double blind controlled crossover long term study.
CRONBERG S, Welin C, Henriksson L, Hellsten S, Persson K, Stenberg P
Br Med J (Clin Res Ed). 1987; 294(6586):1507-8.
PMID: 3111615
PMC: 1246667.
DOI: 10.1136/bmj.294.6586.1507.
Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women.
Nicolle L, Harding G, Thompson M, Kennedy J, Urias B, Ronald A
Antimicrob Agents Chemother. 1989; 33(7):1032-5.
PMID: 2675752
PMC: 176057.
DOI: 10.1128/AAC.33.7.1032.
The life and times of the Enterococcus.
Murray B
Clin Microbiol Rev. 1990; 3(1):46-65.
PMID: 2404568
PMC: 358140.
DOI: 10.1128/CMR.3.1.46.
Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole.
Ronald A, Harding C, Mathias R, Wong C, Muir P
Can Med Assoc J. 1975; 112(13 Spec No):13-6.
PMID: 1137829
PMC: 1956444.
Editorial: urinary tract infection.
Ronald A
Can Med Assoc J. 1975; 112(8):927-8.
PMID: 1131760
PMC: 1956066.
